These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 17962051

  • 1. The MTHFR polymorphism C677T in adult patients with acute lymphoblastic leukemia is associated with an increased prevalence of cytogenetic abnormalities.
    Gallegos-Arreola MP, Figuera LE, Delgado JL, Puebla-Pérez AM, Zúñiga-González GM.
    Blood Cells Mol Dis; 2008; 40(2):244-5. PubMed ID: 17962051
    [No Abstract] [Full Text] [Related]

  • 2. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
    Oh D, Kim NK, Jang MJ, Kim HC, Lee JH, Lee JA, Ahn MJ, Kim CS, Kim HS, Park S, Chio HS, Min YH, HOGS Investigators.
    Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
    [Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T.
    Cancer Res; 2005 Mar 15; 65(6):2482-7. PubMed ID: 15781665
    [Abstract] [Full Text] [Related]

  • 4. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.
    Kim NK, Chong SY, Jang MJ, Hong SH, Kim HS, Cho EK, Lee JA, Ahn MJ, Kim CS, Oh D.
    Anticancer Res; 2006 Mar 15; 26(4B):2879-81. PubMed ID: 16886608
    [Abstract] [Full Text] [Related]

  • 5. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
    Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F, Fidani L, Koliouskas D, Mirtsou V.
    Pediatr Blood Cancer; 2006 Aug 15; 47(2):147-51. PubMed ID: 16123993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
    Chiusolo P, Reddiconto G, Farina G, Mannocci A, Fiorini A, Palladino M, La Torre G, Fianchi L, Sorà F, Laurenti L, Leone G, Sica S.
    Leuk Res; 2007 Dec 15; 31(12):1669-74. PubMed ID: 17512587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience.
    Frikha R, Rebai T, Lobna BM, Frikha F, Mdhaffar M, Frikha I, Elloumi M, Bouayed N.
    J Oncol Pharm Pract; 2019 Jul 15; 25(5):1182-1186. PubMed ID: 30545275
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Meta-analyzing the link between MTHFR C677T genotype and susceptibility to childhood ALL.
    Goyal RK, Cooper JD.
    Pediatr Blood Cancer; 2012 Apr 15; 58(4):483-4. PubMed ID: 22180054
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MTHFR and ALL risk: a challenge.
    Toffoli G, Innocenti F.
    Leuk Lymphoma; 2006 Jul 15; 47(7):1203-4. PubMed ID: 16923547
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.